Advertisement
CBT vs OEC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a StrongBuy and OEC is a StrongBuy.
CBT's RSI Indicator ascending out of oversold territory
The RSI Indicator for CBT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 20 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 60 cases where CBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for CBT just turned positive on October 22, 2026. Looking at past instances where CBT's MACD turned positive, the stock continued to rise in 30 of 49 cases over the following month. The odds of a continued upward trend are 61%.
Following a +2.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in 205 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
CBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBT as a result. In 66 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The 50-day moving average for CBT moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Aroon Indicator for CBT entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.286) is normal, around the industry mean (2.284). P/E Ratio (19.791) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.548). Dividend Yield (0.027) settles around the average of (0.039) among similar stocks. P/S Ratio (1.138) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
OEC's RSI Oscillator is remaining in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +1.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where OEC advanced for three days, in 213 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
OEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 59 cases where OEC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OEC as a result. In 71 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for OEC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
OEC moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for OEC entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.589) is normal, around the industry mean (2.284). P/E Ratio (-2.329) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (1.548). Dividend Yield (0.021) settles around the average of (0.039) among similar stocks. P/S Ratio (0.177) is also within normal values, averaging (48.960).
The Tickeron Seasonality Score of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. OEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
CBT | OEC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 68 | 100 | |
SMR RATING 1..100 | 65 | 96 | |
PRICE GROWTH RATING 1..100 | 60 | 85 | |
P/E GROWTH RATING 1..100 | 5 | 12 | |
SEASONALITY SCORE 1..100 | 50 | 45 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OEC's Valuation (25) in the Chemicals Specialty industry is somewhat better than the same rating for CBT (60) in the Industrial Specialties industry. This means that OEC’s stock grew somewhat faster than CBT’s over the last 12 months.
CBT's Profit vs Risk Rating (68) in the Industrial Specialties industry is in the same range as OEC (100) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.
CBT's SMR Rating (65) in the Industrial Specialties industry is in the same range as OEC (96) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.
CBT's Price Growth Rating (60) in the Industrial Specialties industry is in the same range as OEC (85) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.
CBT's P/E Growth Rating (5) in the Industrial Specialties industry is in the same range as OEC (12) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.
| CBT | OEC | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 86% |
| Stochastic ODDS (%) | 4 days ago 70% | 4 days ago 76% |
| Momentum ODDS (%) | 4 days ago 68% | 4 days ago 83% |
| MACD ODDS (%) | 4 days ago 61% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 68% | 4 days ago 77% |
| TrendMonth ODDS (%) | 4 days ago 69% | 4 days ago 77% |
| Advances ODDS (%) | 8 days ago 67% | 8 days ago 70% |
| Declines ODDS (%) | 4 days ago 68% | 4 days ago 77% |
| BollingerBands ODDS (%) | 4 days ago 69% | 4 days ago 74% |
| Aroon ODDS (%) | 4 days ago 70% | 4 days ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBT’s FA Score shows that 1 FA rating(s) are green while OEC’s FA Score has 2 green FA rating(s).
- CBT’s FA Score: 1 green, 4 red.
- OEC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBT’s TA Score shows that 5 TA indicator(s) are bullish while OEC’s TA Score has 3 bullish TA indicator(s).
- CBT’s TA Score: 5 bullish, 4 bearish.
- OEC’s TA Score: 3 bullish, 6 bearish.
Price Growth
CBT (@Chemicals: Specialty) experienced а -4.54% price change this week, while OEC (@Chemicals: Specialty) price change was -29.29% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +0.43%. For the same industry, the average monthly price growth was -0.87%, and the average quarterly price growth was -8.55%.
Reported Earning Dates
CBT is expected to report earnings on Feb 08, 2027.
OEC is expected to report earnings on Feb 18, 2027.
Industries' Descriptions
@Chemicals: Specialty (+0.43% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
CBT and
Correlation & Price change
A.I.dvisor indicates that over the last year, CBT has been loosely correlated with ASIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CBT jumps, then ASIX could also see price increases.
| Ticker / NAME | Correlation To CBT | 1D Price Change % | ||
|---|---|---|---|---|
| CBT | 100% | -2.63% | ||
| ASIX - CBT | 62% Loosely correlated | +3.57% | ||
| OLN - CBT | 61% Loosely correlated | -4.15% | ||
| HUN - CBT | 55% Loosely correlated | -3.47% | ||
| DOW - CBT | 55% Loosely correlated | -1.81% | ||
| AVNT - CBT | 54% Loosely correlated | +0.33% | ||
More | ||||
OEC and
Correlation & Price change
A.I.dvisor indicates that over the last year, OEC has been loosely correlated with KRO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if OEC jumps, then KRO could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SETH | 35.79 | 0.30 | +0.85% |
| ProShares Short Ether ETF (SETH) | |||
| SHLD | 58.20 | 0.17 | +0.29% |
| Global X Defense Tech ETF (SHLD) | |||
| PJP | 126.78 | 0.32 | +0.25% |
| Invesco Pharmaceuticals ETF (PJP) | |||
| DEED | 20.92 | 0.02 | +0.10% |
| First Trust Securitized Plus ETF (DEED) | |||
| SECR | 24.63 | N/A | +0.01% |
| NYLIM MacKay Securitized Income ETF (SECR) | |||